Carole Brosseau

Title: Carole Brosseau: Innovator in Lung Allograft Research

Introduction

Carole Brosseau is a notable inventor based in Coueron, France. She has made significant contributions to the field of medical research, particularly in the area of lung allograft survival. Her innovative work has the potential to improve patient outcomes in transplant medicine.

Latest Patents

Carole Brosseau holds a patent titled "CD24CD38 transitional B cells and CD9 as new biomarker of long-term human lung allograft survival." This invention relates to an in vitro method for determining the risk of chronic lung graft dysfunction in a human subject. The method involves measuring the level of CD9B cells in a blood sample, comparing it with reference values, and determining the risk of chronic lung graft dysfunction based on this comparison. This patent highlights her commitment to advancing medical diagnostics.

Career Highlights

Throughout her career, Carole has worked with esteemed institutions such as Université de Nantes and the Institut National de la Santé et de la Recherche Médicale. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Carole Brosseau has collaborated with notable colleagues, including Maxim Durand and Antoine Magnan. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Carole Brosseau's contributions to lung allograft research exemplify her dedication to improving medical science. Her innovative patent and collaborations with esteemed institutions and colleagues underscore her role as a significant figure in the field.